Nimustine Hydrochloride
Nimustine Hydrochloride is a nitrosourea alkylating agent investigated for the treatment of glioblastoma in clinical trials. It is utilized in research to study its cytotoxic effects and mechanisms of action in both in vitro cell cultures and in vivo animal models of brain tumors.
Product Specifications
CAS Number
55661-38-6
Product Name Alternative
Inhibitor, inhibit, Nidran Hydrochloride, Nidran hydrochloride, Nimustine, Nimustine Hydrochloride, Apoptosis, ACNU, Crosslinker, DNASynthesis, DNA Synthesis, DNA/RNA Synthesis, DNAAlkylator, DNA Alkylator/Crosslinker, DNA Alkylator, RNA Synthesis, RNASynthesis
Field of Research
Cell Biology, Molecular Biology, Pharmacology & Drug Discovery, Signal Transduction
Purity
98.80% (May vary between batches)
Solubility
DMSO:55 mg/mL (177.91 mM) ;10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (6.47 mM)
Smiles
Cl.Cc1ncc (CNC (=O) N (CCCl) N=O) c (N) n1
Molecular Formula
C9H14Cl2N6O2
Molecular Weight
309.15
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
